Top

BMC Public Health

Published in:

Open Access 01-12-2021 | Obesity | Research

COVID-19, body mass index and cholesterol: an ecological study using global data

Authors: Mohammad Sarmadi, S. Mohammad Ahmadi-Soleimani, Mohammad Fararouei, Mostafa Dianatinasab

Published in: BMC Public Health | Issue 1/2021

Abstract

Background

Coronavirus disease 2019 (COVID-19) is now globally considered a serious economic, social and health threat. A wide range of health related factors including Body Mass Index (BMI) is reported to be associated with the disease. In the present study, we analyzed global databases to assess the correlation of BMI and cholesterol with the risk of COVID-19.

Methods

In this ecological study, we used age-standardized BMI and cholesterol levels as well as the incidence and mortality ratio of COVID-19 at the national-levels obtained from the publicly available databases such as the World Health Organization (WHO) and NCD Risk Factor Collaboration (NCD-RisC). Bivariate correlation analysis was applied to assess the correlations between the study variables. Mean differences (standard deviation: SD) of BMI and cholesterol levels of different groups were tested using independent sample t-test or Mann–Whitney rank test as appropriate. Multivariable linear regression analysis was performed to identify variables affecting the incidence and mortality ratio of COVID-19.

Results

Incidence and mortality ratio of COVID-19 were significantly higher in developed (29,639.85 ± 20,210.79 for cases and 503.24 ± 414.65 for deaths) rather than developing (8153.76 ± 11,626.36 for cases and 169.95 ± 265.78 for deaths) countries (P < 0.01). Results indicated that the correlations of BMI and cholesterol level with COVID-19 are stronger in countries with younger population. In general, the BMI and cholesterol level were positively correlated with COVID-19 incidence ratio (β = 2396.81 and β = 30,932.80, p < 0.01,‌ respectively) and mortality ratio (β = 38.18 and β = 417.52, p < 0.05,‌ respectively) after adjusting for socioeconomic and demographic factors.

Conclusion

Countries with higher BMI or cholesterol at aggregate levels had a higher ratios of COVID-19 incidence and mortality. The aggregated level of cholesterol and BMI are important risk factors for COVID-19 major outcomes, especially in developing countries with younger populations. We recommend monitoring and promotion of health indicices to better prevent morbidity and mortality of COVID-19.

Available only for authorised users

Guan W-j, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.CrossRefPubMed

WHO. WHO Coronavirus Disease (COVID-19) Dashboard. 2021 [cited 2021 29 June]; Available from: https://covid19.who.int/.

Arbel Y, Fialkoff C, Kerner A, Kerner M. Can reduction in infection and mortality rates from coronavirus be explained by an obesity survival paradox? An analysis at the US statewide level. Int J Obes (Lond). 2020;44(11):2339–42. https://doi.org/10.1038/s41366-020-00680-7.CrossRef

Sarmadi M, Rahimi S, Evensen D, Kazemi Moghaddam V. Interaction between meteorological parameters and COVID-19: an ecological study on 406 authorities of the UK. Environ Sci Pollut Res. 2021:16. https://doi.org/10.1007/s11356-021-15279-2.

Sarmadi, M., Moghanddam, V.K., Dickerson, A.S. et al. Association of COVID-19 distribution with air quality, sociodemographic factors, and comorbidities: an ecological study of US states. Air Qual, Atmos Health. 2020;14: 455–465. https://doi.org/10.1007/s11869-020-00949-w.

Sarmadi M, Marufi N, Moghaddam VK. Association of COVID-19 global distribution and environmental and demographic factors: an updated three-month study. Environ Res. 2020;188:109748. https://doi.org/10.1016/j.envres.2020.109748.CrossRefPubMedPubMedCentral

Li H, Xu XL, Dai DW, Huang ZY, Ma Z, Guan YJ. Air pollution and temperature are associated with increased COVID-19 incidence: a time series study. Int J Infect Dis. 2020;97:278–82. https://doi.org/10.1016/j.ijid.2020.05.076.CrossRefPubMedPubMedCentral

Bolaño-Ortiz TR, Camargo-Caicedo Y, Puliafito SE, Ruggeri MF, Bolaño-Diaz S, Pascual-Flores R, et al. Spread of SARS-CoV-2 through Latin America and the Caribbean region: a look from its economic conditions, climate and air pollution indicators. Environ Res. 2020;191:109938. https://doi.org/10.1016/j.envres.2020.109938.CrossRefPubMedPubMedCentral

Anastassopoulou C, Gkizarioti Z, Patrinos GP, Tsakris A. Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity. Hum Genomics. 2020;14(1):1–8. https://doi.org/10.1186/s40246-020-00290-4.CrossRef

10.

Shelton, J.F., Shastri, A.J., Ye, C. et al. Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity. Nat Genet 53, 801–808 (2021). https://doi.org/10.1038/s41588-021-00854-7.

11.

Hendren NS, de Lemos JA, Ayers C, Das SR, Rao A, Carter S, Rosenblatt A, Walchok J, Omar W, Khera R, Hegde AA, Drazner MH, Neeland IJ, Grodin JL. Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry. Circulation. 2021;143(2):135-144. https://doi.org/10.1161/CIRCULATIONAHA.120.051936.

12.

Anderson MR, Geleris J, Anderson DR, Zucker J, Nobel YR, Freedberg D, et al. Body mass index and risk for intubation or death in SARS-CoV-2 infection: a retrospective cohort study. Ann Intern Med. 2020;173(10):782–90. https://doi.org/10.7326/M20-3214.CrossRefPubMed

13.

Tartof SY, Qian L, Hong V, Wei R, Nadjafi RF, Fischer H, et al. Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization. Ann Intern Med. 2020;173(10):773–81. https://doi.org/10.7326/M20-3742.CrossRefPubMed

14.

Aghili SMM, Ebrahimpur M, Arjmand B, Shadman Z, Pejman Sani M, Qorbani M, et al. Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis. Int J Obes (Lond). 2021;45(5):998–1016. https://doi.org/10.1038/s41366-021-00776-8.CrossRef

15.

Jain S, Chaves SS. Obesity and influenza. Clin Infect Dis. 2011;53(5):422–4. https://doi.org/10.1093/cid/cir448.CrossRefPubMed

16.

Kwong JC, Campitelli MA, Rosella LC. Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study. Clin Infect Dis. 2011;53(5):413–21. https://doi.org/10.1093/cid/cir442.CrossRefPubMedPubMedCentral

17.

Centers for Disease Control Prevention. COVIDView: A weekly surveillance summary of US COVID-19 activity. Key updates for week 2020 [cited October 16, 2020]; Available from: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html.

18.

Liu Y, Mao B, Liang S, Yang JW, Lu HW, Chai YH, et al. Association between age and clinical characteristics and outcomes of COVID-19. Eur Respir J. 2020;55(5). https://doi.org/10.1183/13993003.01112-2020.

19.

Aung N, et al. Causal inference for genetic obesity, cardiometabolic profile and COVID-19 susceptibility: a Mendelian randomization study. Front Genet. 2020;11:1417.CrossRef

20.

Huang W, Li C, Wang Z, Wang H, Zhou N, Jiang J, et al. Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases. Sci China Life Sci. 2020;63(11):1678–87. https://doi.org/10.1007/s11427-020-1733-4.CrossRefPubMed

21.

Wang G, Zhang Q, Zhao X, Dong H, Wu C, Wu F, et al. Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study. Lipids Health Dis. 2020;19(1):1–7. https://doi.org/10.1186/s12944-020-01382-9.CrossRefPubMedPubMedCentral

22.

Hu X, Chen D, Wu L, He G, Ye W. Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection. Clin Chim Acta. 2020;510:105–10. https://doi.org/10.1016/j.cca.2020.07.015.CrossRefPubMedPubMedCentral

23.

Wei X, Zeng W, Su J, Wan H, Yu X, Cao X, et al. Hypolipidemia is associated with the severity of COVID-19. J Clin Lipidol. 2020;14(3):297–304. https://doi.org/10.1016/j.jacl.2020.04.008.CrossRefPubMedPubMedCentral

24.

Garrison RJ, Wilson PW, Castelli WP, Feinleib M, Kannel WB, McNamara PM. Obesity and lipoprotein cholesterol in the Framingham offspring study. Metabolism. 1980;29(11):1053–60. https://doi.org/10.1016/0026-0495(80)90216-4.CrossRefPubMed

25.

Lipsitch M, Swerdlow DL, Finelli L. Defining the epidemiology of Covid-19—studies needed. N Engl J Med. 2020;382(13):1194–6. https://doi.org/10.1056/NEJMp2002125.CrossRefPubMed

26.

Sarmadi M, Kakhki S, Foroughi M, Abadi TSH, Nayyeri S, Moghadam VK, et al. Hospitalization period of COVID-19 for future plans in hospital. Br J Surg. 2020;107(10):e427–8. https://doi.org/10.1002/bjs.11871.CrossRefPubMedPubMedCentral

27.

Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014;12(12):1500–24. https://doi.org/10.1016/j.ijsu.2014.07.014.CrossRefPubMed

28.

Von Elm E, et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Br Med J. 2007;335(7624):806–8. https://doi.org/10.1136/bmj.39335.541782.AD.CrossRef

29.

Xu Z, Yu D, Yin X, Zheng F, Li H. Socioeconomic status is associated with global diabetes prevalence. Oncotarget. 2017;8(27):44434–9. https://doi.org/10.18632/oncotarget.17902.CrossRefPubMedPubMedCentral

30.

NCD Risk Factor Collaboration (NCD-RisC). DATA DOWNLOADS, Download files containing country risk factor data. 2020 [cited 2020, October 20]; Available from: https://www.ncdrisc.org/data-downloads.html.

31.

WHO. Body mass index - BMI. 2020 [cited 2020]; Available from: https://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi.

32.

Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) results. 2020; Available from: http://ghdx.healthdata.org/gbd-results-tool.

33.

Zhi G, et al. “Obesity paradox” in acute respiratory distress syndrome: asystematic review and meta-analysis. PLoS One. 2016;11(9):e0163677.CrossRefPubMedCentralPubMed

34.

King P, Mortensen EM, Bollinger M, Restrepo MI, Copeland LA, Pugh MJV, et al. Impact of obesity on outcomes for patients hospitalised with pneumonia. Eur Respir J. 2013;41(4):929–34. https://doi.org/10.1183/09031936.00185211.CrossRefPubMed

35.

Nie W, Zhang Y, Jee SH, Jung KJ, Li B, Xiu Q. Obesity survival paradox in pneumonia: a meta-analysis. BMC Med. 2014;12(1):61. https://doi.org/10.1186/1741-7015-12-61.CrossRefPubMedPubMedCentral

36.

Sattar N, Ho FK, Gill JMR, Ghouri N, Gray SR, Celis-Morales CA, et al. BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: preliminary findings from UK biobank. Diabetes Metab Syndr Clin Res Rev. 2020;14(5):1149–51. https://doi.org/10.1016/j.dsx.2020.06.060.CrossRef

37.

Jung C-Y, Park H, Kim DW, Lim H, Chang JH, Choi YJ, et al. Association between body mass index and risk of coronavirus disease 2019 (COVID-19): a nationwide case-control study in South Korea. Clin Infect Dis. 2020. https://doi.org/10.1093/cid/ciaa1257.

38.

Nakeshbandi M, Maini R, Daniel P, Rosengarten S, Parmar P, Wilson C, et al. The impact of obesity on COVID-19 complications: a retrospective cohort study. Int J Obes (Lond). 2020;44(9):1832–7. https://doi.org/10.1038/s41366-020-0648-x.CrossRef

39.

Yates T, Razieh C, Zaccardi F, Rowlands AV, Seidu S, Davies MJ, et al. Obesity, walking pace and risk of severe COVID-19 and mortality: analysis of UK biobank. Int J Obes (Lond). 2021;45(5):1155–9. https://doi.org/10.1038/s41366-021-00771-z.CrossRef

40.

Peters SA, MacMahon S, Woodward M. Obesity as a risk factor for COVID-19 mortality in women and men in the UK biobank: comparisons with influenza/pneumonia and coronary heart disease. Diabetes Obes Metab. 2021;23(1):258–62. https://doi.org/10.1111/dom.14199.CrossRefPubMed

41.

Kang Z, Luo S, Gui Y, Zhou H, Zhang Z, Tian C, et al. Obesity is a potential risk factor contributing to clinical manifestations of COVID-19. Int J Obes (Lond). 2020;44(12):2479–85. https://doi.org/10.1038/s41366-020-00677-2.CrossRef

42.

Onis Md, et al. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85(09):660–7. https://doi.org/10.2471/BLT.07.043497.CrossRefPubMedPubMedCentral

43.

Abarca-Gómez L, Abdeen ZA, Hamid ZA, Abu-Rmeileh NM, Acosta-Cazares B, Acuin C, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–42. https://doi.org/10.1016/S0140-6736(17)32129-3.CrossRef

44.

Cunningham JW, et al. Clinical outcomes in young US adults hospitalized with COVID-19. JAMA Intern Med. 2021181(3):379-381. https://doi.org/10.1001/jamainternmed.2020.5313.

45.

Zhou F, Yu T, du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62. https://doi.org/10.1016/S0140-6736(20)30566-3.CrossRefPubMedPubMedCentral

46.

Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Jama. 2003;289(1):76–9. https://doi.org/10.1001/jama.289.1.76.CrossRefPubMed

47.

Hendren NS, Drazner MH, Bozkurt B, Cooper LT Jr. Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation. 2020;141(23):1903–14. https://doi.org/10.1161/CIRCULATIONAHA.120.047349.CrossRefPubMedPubMedCentral

48.

Kassir R. Risk of COVID-19 for patients with obesity. Obes Rev. 2020;21(6):e13034. https://doi.org/10.1111/obr.13034.CrossRefPubMedPubMedCentral

49.

Al-Benna S. Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients. Obes Med. 2020;19:100283. https://doi.org/10.1016/j.obmed.2020.100283.CrossRefPubMedPubMedCentral

50.

Gong MN, Bajwa EK, Thompson BT, Christiani DC. Body mass index is associated with the development of acute respiratory distress syndrome. Thorax. 2010;65(1):44–50. https://doi.org/10.1136/thx.2009.117572.CrossRefPubMed

51.

Huttunen R, Syrjänen J. Obesity and the risk and outcome of infection. Int J Obes (Lond). 2013;37(3):333–40. https://doi.org/10.1038/ijo.2012.62.CrossRef

52.

Peters MC, McGrath K, Hawkins GA, Hastie AT, Levy BD, Israel E, et al. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. Lancet Respir Med. 2016;4(7):574–84. https://doi.org/10.1016/S2213-2600(16)30048-0.CrossRefPubMedPubMedCentral

53.

Zhang X, et al. Systemic inflammation mediates the detrimental effects of obesity on asthma control. In: Allergy & Asthma Proceedings; 2018.

54.

Nieman DC, et al. Influence of obesity on immune function. J Am Diet Assoc. 1999;99(3):294–9. https://doi.org/10.1016/S0002-8223(99)00077-2.CrossRefPubMed

55.

Francisco V, Pino J, Campos-Cabaleiro V, Ruiz-Fernández C, Mera A, Gonzalez-Gay MA, et al. Obesity, fat mass and immune system: role for leptin. Front Physiol. 2018;9:640. https://doi.org/10.3389/fphys.2018.00640.CrossRefPubMedPubMedCentral

56.

Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, Sammon AB, et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond). 2012;36(8):1072–7. https://doi.org/10.1038/ijo.2011.208.CrossRef

57.

Solt CM, et al. Obesity-induced immune dysfunction and immunosuppression: TEM observation of visceral and subcutaneous lymph node microarchitecture and immune cell interactions. Horm Mol Biol Clin Invest. 2019;39(14). https://doi.org/10.1515/hmbci-2018-0083.

58.

Wei C, et al. Cholesterol metabolism--impact for SARS-CoV-2 infection prognosis, entry, and antiviral therapies. MedRxiv.2020. 25p. https://doi.org/10.1101/2020.04.16.20068528.

59.

Hu X, et al. Low serum cholesterol level among patients with COVID-19 infection in Wenzhou, China. SSRN. 2020; 21. https://dx.doi.org/10.2139/ssrn.3544826.

60.

Feng Q, Wei WQ, Chaugai S, Leon BGC, Mosley JD, Leon DAC, et al. Association between low-density lipoprotein cholesterol levels and risk for sepsis among patients admitted to the hospital with infection. JAMA Netw Open. 2019;2(1):–e187223. https://doi.org/10.1001/jamanetworkopen.2018.7223.

61.

Abu-Farha M, Thanaraj TA, Qaddoumi MG, Hashem A, Abubaker J, al-Mulla F. The role of lipid metabolism in COVID-19 virus infection and as a drug target. Int J Mol Sci. 2020;21(10):3544. https://doi.org/10.3390/ijms21103544.CrossRefPubMedCentral

62.

Wu Q, Zhou L, Sun X, Yan Z, Hu C, Wu J, et al. Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep. 2017;7(1):1–12. https://doi.org/10.1038/s41598-017-09536-z.CrossRef

63.

Guo H, Huang M, Yuan Q, Wei Y, Gao Y, Mao L, et al. The important role of lipid raft-mediated attachment in the infection of cultured cells by coronavirus infectious bronchitis virus beaudette strain. PLoS One. 2017;12(1):e0170123. https://doi.org/10.1371/journal.pone.0170123.CrossRefPubMedPubMedCentral

64.

Susser M. The logic in ecological: I. The logic of analysis. Am J Public Health. 1994;84(5):825–9. https://doi.org/10.2105/AJPH.84.5.825.CrossRefPubMedPubMedCentral

65.

Neumark Y. What can ecological studies tell us about death? Isr J Health Policy Res. 2017;6(1):52. https://doi.org/10.1186/s13584-017-0176-x.CrossRefPubMedPubMedCentral

66.

Ginsberg GM, Tulchinsky TH, Salahov E, Clayman M. Standardized mortality ratios by region of residence, Israel, 1987-1994: a tool for public health policy. Public Health Rev. 2003;31(2):111–31.PubMed

67.

Oggioni C, Cena H, Wells JCK, Lara J, Celis-Morales C, Siervo M. Association between worldwide dietary and lifestyle patterns with total cholesterol concentrations and DALYs for infectious and cardiovascular diseases: an ecological analysis. J Epidemiol Glob Health. 2015;5(4):315–25. https://doi.org/10.1016/j.jegh.2015.02.002.CrossRefPubMedPubMedCentral

68.

Munnangi S, Boktor SW. Epidemiology of study design; 2017.

69.

Pearce N. The ecological fallacy strikes back. J Epidemiol Community Health. 2000;54(5):326–7. https://doi.org/10.1136/jech.54.5.326.CrossRefPubMedPubMedCentral

70.

Barratt, H. and M. Kirwan. Public Health Textbook: Research methods appropriate to public health practice, including epidemiology, statistical methods and other methods of enquiry including qualitative research methods. 2009 [cited 2021 21 June]; Available from: https://www.healthknowledge.org.uk/public-health-textbook.

Title: COVID-19, body mass index and cholesterol: an ecological study using global data
Authors: Mohammad Sarmadi
S. Mohammad Ahmadi-Soleimani
Mohammad Fararouei
Mostafa Dianatinasab
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Obesity
Obesity
COVID-19
Published in: BMC Public Health / Issue 1/2021
Electronic ISSN: 1471-2458
DOI: https://doi.org/10.1186/s12889-021-11715-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

COVID-19, body mass index and cholesterol: an ecological study using global data

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2021

Characterizing nicotine exposure among a community sample of non-daily smokers in the United States

Association between incarceration and incident cardiovascular disease events: results from the CARDIA cohort study

Burnout and peritraumatic distress of healthcare workers in the COVID-19 pandemic

Trends in cervical cancer mortality in China from 1989 to 2018: an age-period-cohort study and Joinpoint analysis

Mental health symptoms and inflammatory markers among HIV infected patients in Tanzania

Optimal cutoff values for anthropometric indices of obesity as discriminators of metabolic abnormalities in Korea: results from a Health Examinees study